previously few years, the united kingdom has witnessed a revolution in medical excess weight‑decline solutions — in the introduction of semaglutide (Wegovy®) on the rising popularity of tirzepatide (Mounjaro®). Now, A different identify is drawing attention in both clinical and general public wel